The role of flumazenil in the treatment of benzodiazepine dependence: Physiological and psychological profiles

Journal of Psychopharmacology

Volumn 23, Issue 4, 2009, Pages 401-409

  Hood, S ^a   O'Neil, G ^b   Hulse, G ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b Australian Medical Procedures Research Foundation (AMPRF)   (Australia)

Author keywords

Benzodiazepine withdrawal; Case series; Comorbidity; Flumazenil; Infusion; Naturalistic; Safety

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; BUPRENORPHINE; DEXAMPHETAMINE; DIAZEPAM; FLUMAZENIL; NALTREXONE; NITRAZEPAM; OXAZEPAM; PAROXETINE; QUETIAPINE; TEMAZEPAM;

ABDOMINAL MUSCLE PAIN; ADULT; ALCOHOLISM; ARTICLE; ATTENTION DEFICIT DISORDER; AUSTRALIA; BACK MUSCLE PAIN; BACKACHE; BALLOON CATHETER; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTINUOUS INFUSION; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG INFUSION; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; LOW DRUG DOSE; MALE; MYALGIA; OPIATE ADDICTION; PANIC; PRIORITY JOURNAL; SYMPTOM; VEIN THROMBOSIS; WITHDRAWAL SYNDROME;

ADULT; BENZODIAZEPINES; BLOOD PRESSURE; COHORT STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; FLUMAZENIL; GABA MODULATORS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MENTAL DISORDERS; RESPIRATION; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 65649094053     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108100322     Document Type: Article

References (39)

1. Ali NJ, Olsen RW, (2001) Chronic benzodiazepine treatment of cells expressing recombinant GABA(A) receptors uncouples allosteric binding: studies on possible mechanisms. J Neurochem 79: 1100 - 1108.
2. Ashton H, (1991) Protracted withdrawal syndromes from benzodiazepines. J Subst Abuse Treat 8: 19 - 28.
3. Ashton H, (2005) The diagnosis and management of benzodiazepine dependence. Curr Opin Psychiatry 18: 249 - 255.
4. Assmann SF, Pocock SJ, Enos LE, Kasten LE, (2000) Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 355: 1064 - 1069.
5. Bell C, Forshall S, Adrover M, Nash J, Hood S, Argyropoulos S, (2002) Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. J Psychopharmacol 16: 5 - 14.
6. Bergman H, Borg S, Engelbrektson K, Vikander B, (1989) Dependence on sedative-hypnotics: neuropsychological impairment, field dependence and clinical course in a 5-year follow-up study. Br J Addict 84: 547 - 553.
7. Bond AJ, Lader MH, (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: 211 - 218.
8. Bonetti EP, Pieri L, Cumin R, Schaffner R, Pieri M, Gamzu ER, (1982) Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology (Berl) 78: 8 - 18.
9. Chouinard G, (2004) Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound. J Clin Psychiatry 65 (Suppl. 5). 7 - 12.
10. Coupland NJ, Bell C, Potokar JP, Dorkins E, Nutt DJ, (2000) Flumazenil challenge in social phobia. Depress Anxiety 11: 27 - 30.
11. Covi L, Lipman RS, Pattison JH, Derogatis LR, Uhlenhuth EH, (1973) Length of treatment with anxiolytic sedatives and response to their sudden withdrawal. Acta Psychiatr Scand 49: 51 - 64.
12. de las CC, Sanz, EJ, de la Fuente, JA, Padilla, J, Berenguer, JC (2000) The Severity of Dependence Scale (SDS) as screening test for benzodiazepine dependence: SDS validation study. Addiction 95: 245 - 250.
13. Denis C, Fatseas M, Lavie E, Auriacombe M, (2006) Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings (CD005194). Cochrane Database of Systematic Reviews 3: doi: 10.1002/14651858.CD005194.pub2.
14. Dong Y, Winslow M, Chan YH, Subramaniam M, Whelan G, (2007) Benzodiazepine dependence in Singapore. Subst Use Misuse 42: 1345 - 1352.
15. File SE, Pellow S, (1986) Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology (Berl) 88: 1 - 11.
16. Fresco DM, Coles ME, Heimberg RG, Liebowitz MR, Hami S, Stein MB, (2001) The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats. Psychol Med 31: 1025 - 1035.
17. Gerra G, Zaimovic A, Giusti F, Moi G, Brewer C, (2002) Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study. Addict Biol 7: 385 - 395.
18. Harrison-Read PE, Tyrer P, Lawson C, Lack S, Fernandes C, File SE, (1996) Flumazenil-precipitated panic and dysphoria in patients dependent on benzodiazepines: a possible aid to abstinence. J Psychopharmacol 10: 89 - 97.
19. Heberlein A, Bleich S, Kornhuber J, Hillemacher T, (2008) Neuroendocrine pathways in benzodiazepine dependence: new targets for research and therapy. Hum Psychopharmacol 23: 171 - 181.
20. Hollister LE, Motzenbecker F, Degan R, (1961) Withdrawal reactions from chlordiazepoxide ("Libriumg"). Psychopharmacologia 2: 63 - 68.
21. Hulse G, White J, Cape G, (2002) The Management of Alcohol and Other Drug Problems. Oxford University Press, Melbourne.
22. Jazvinscak JM, Svob SD, Vlainic J, Pericic D, (2008) The role of transcriptional and translational mechanisms in flumazenil-induced up-regulation of recombinant GABA(A) receptors. Neurosci Res 61: 234 - 241.
23. Jurand A, Martin LV, (1994) Cleft palate and open eyelids inducing activity of lorazepam and the effect of flumazenil, the benzodiazepine antagonist. Pharmacol Toxicol 74: 228 - 235.
24. Lader M, (1983) Dependence on benzodiazepines. J Clin Psychiatry 44: 121 - 127.
25. McNair DM, Lorr M, Droppleman LF, (1988) Manual for the Profile of Mood States. San Diego: Educational and Industrial Testing Service.
26. Nutt DJ, Costello MJ, (1988) Rapid induction of lorazepam dependence and reversal with flumazenil. Life Sci 43: 1045 - 1053.
27. Petursson H, Lader MH, (1981a) Withdrawal from long-term benzodiazepine treatment. Br Med J (Clin Res Ed) 283: 643 - 645.
28. Petursson H, Lader MH, (1981b) Withdrawal from long-term benzodiazepine treatment. Br Med J (Clin Res Ed) 283: 643 - 645.
29. Potokar J, Coupland N, Glue P, Groves S, Malizia A, Bailey J, (1997) Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study. Alcohol Alcohol 32: 605 - 611.
30. Quaglio G, Lugoboni F, Fornasiero A, Lechi A, Gerra G, Mezzelani P, (2005) Dependence on zolpidem: two case reports of detoxification with flumazenil infusion. Int Clin Psychopharmacol 20: 285 - 287.
31. Sacristan JA, Soto J, Galende I, Hylan TR, (1998) Randomized database studies: a new method to assess drugs' effectiveness. J Clin Epidemiol 51: 713 - 715.
32. Saxon L, Hjemdahl P, Hiltunen AJ, Borg S, (1997) Effects of flumazenil in the treatment of benzodiazepine withdrawal-a double-blind pilot study. Psychopharmacology (Berl) 131: 153 - 160.
33. Schlappi B, Bonetti EP, Burgin H, Strobel R, (1988) Toxicological investigations with the benzodiazepine antagonist flumazenil. Arzneimittelforschung 38: 247 - 250.
34. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl. 20). 22 - 33.
35. Smith BJ, Bickel WK, (1999) Flumazenil discrimination by humans under a two-response and a novel-response procedure. J Pharmacol Exp Ther 291: 1257 - 1268.
36. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA, (1983) Manual for the Stait Trait Anxiety Inventory. Consulting Psychologists' Press, Palo Alto, CA.
37. Thomson JS, Donald C, Lewin K, (2006) Use of Flumazenil in benzodiazepine overdose. Emerg Med J 23: 162.
38. Weinbroum A, Rudick V, Sorkine P, Nevo Y, Halpern P, Geller E, (1996) Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients. Crit Care Med 24: 199 - 206.
39. Wilkins JN, Majewska MD, Van GW, Li SH, Hinken C, Plotkin D, (2005) DHEAS and POMS measures identify cocaine dependence treatment outcome. Psychoneuroendocrinology 30: 18 - 28.